-
Je něco špatně v tomto záznamu ?
Modulating FOXO3 transcriptional activity by small, DBD-binding molecules
J. Hagenbuchner, V. Obsilova, T. Kaserer, N. Kaiser, B. Rass, K. Psenakova, V. Docekal, M. Alblova, K. Kohoutova, D. Schuster, T. Aneichyk, J. Vesely, P. Obexer, T. Obsil, MJ. Ausserlechner,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
I3089-B28
Austrian Science Fund - International
17-33854L
Grantová Agentura České Republiky - International
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2013-01-01
Health & Medicine (ProQuest)
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
31789593
DOI
10.7554/elife.48876
Knihovny.cz E-zdroje
- MeSH
- DNA chemie genetika metabolismus MeSH
- genetická transkripce účinky léků MeSH
- genový knockdown MeSH
- HEK293 buňky MeSH
- knihovny malých molekul chemie metabolismus farmakologie MeSH
- konformace nukleové kyseliny MeSH
- lidé MeSH
- magnetická rezonanční spektroskopie MeSH
- molekulární modely MeSH
- nádorové buněčné linie MeSH
- promotorové oblasti (genetika) genetika MeSH
- protein FOXO3 chemie genetika metabolismus MeSH
- proteinové domény MeSH
- simulace molekulového dockingu MeSH
- stanovení celkové genové exprese metody MeSH
- vazba proteinů MeSH
- vazebná místa genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
FOXO transcription factors are critical regulators of cell homeostasis and steer cell death, differentiation and longevity in mammalian cells. By combined pharmacophore-modeling-based in silico and fluorescence polarization-based screening we identified small molecules that physically interact with the DNA-binding domain (DBD) of FOXO3 and modulate the FOXO3 transcriptional program in human cells. The mode of interaction between compounds and the FOXO3-DBD was assessed via NMR spectroscopy and docking studies. We demonstrate that compounds S9 and its oxalate salt S9OX interfere with FOXO3 target promoter binding, gene transcription and modulate the physiologic program activated by FOXO3 in cancer cells. These small molecules prove the druggability of the FOXO-DBD and provide a structural basis for modulating these important homeostasis regulators in normal and malignant cells.
Department of Organic Chemistry Faculty of Science Charles University Prague Czech Republic
Department of Pediatrics 1 Medical University Innsbruck Innsbruck Austria
Department of Pediatrics 2 Medical University Innsbruck Innsbruck Austria
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023357
- 003
- CZ-PrNML
- 005
- 20211125091235.0
- 007
- ta
- 008
- 201125s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.7554/eLife.48876 $2 doi
- 035 __
- $a (PubMed)31789593
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hagenbuchner, Judith $u Department of Pediatrics II, Medical University Innsbruck, Innsbruck, Austria.
- 245 10
- $a Modulating FOXO3 transcriptional activity by small, DBD-binding molecules / $c J. Hagenbuchner, V. Obsilova, T. Kaserer, N. Kaiser, B. Rass, K. Psenakova, V. Docekal, M. Alblova, K. Kohoutova, D. Schuster, T. Aneichyk, J. Vesely, P. Obexer, T. Obsil, MJ. Ausserlechner,
- 520 9_
- $a FOXO transcription factors are critical regulators of cell homeostasis and steer cell death, differentiation and longevity in mammalian cells. By combined pharmacophore-modeling-based in silico and fluorescence polarization-based screening we identified small molecules that physically interact with the DNA-binding domain (DBD) of FOXO3 and modulate the FOXO3 transcriptional program in human cells. The mode of interaction between compounds and the FOXO3-DBD was assessed via NMR spectroscopy and docking studies. We demonstrate that compounds S9 and its oxalate salt S9OX interfere with FOXO3 target promoter binding, gene transcription and modulate the physiologic program activated by FOXO3 in cancer cells. These small molecules prove the druggability of the FOXO-DBD and provide a structural basis for modulating these important homeostasis regulators in normal and malignant cells.
- 650 _2
- $a vazebná místa $x genetika $7 D001665
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a DNA $x chemie $x genetika $x metabolismus $7 D004247
- 650 _2
- $a protein FOXO3 $x chemie $x genetika $x metabolismus $7 D000071316
- 650 _2
- $a stanovení celkové genové exprese $x metody $7 D020869
- 650 _2
- $a genový knockdown $7 D055785
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční spektroskopie $7 D009682
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a konformace nukleové kyseliny $7 D009690
- 650 _2
- $a promotorové oblasti (genetika) $x genetika $7 D011401
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a proteinové domény $7 D000072417
- 650 _2
- $a knihovny malých molekul $x chemie $x metabolismus $x farmakologie $7 D054852
- 650 _2
- $a genetická transkripce $x účinky léků $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Obsilova, Veronika $u Department of Structural Biology of Signaling Proteins, Institute of Physiology, Division BIOCEV, The Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Kaserer, Teresa $u Pharmaceutical Chemistry, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria. Department of Pediatrics I, Medical University Innsbruck, Innsbruck, Austria. Tyrolean Cancer Research Institute, Innsbruck, Austria.
- 700 1_
- $a Kaiser, Nora $u Department of Pediatrics I, Medical University Innsbruck, Innsbruck, Austria.
- 700 1_
- $a Rass, Bettina $u Department of Pediatrics I, Medical University Innsbruck, Innsbruck, Austria.
- 700 1_
- $a Psenakova, Katarina $u Department of Structural Biology of Signaling Proteins, Institute of Physiology, Division BIOCEV, The Czech Academy of Sciences, Prague, Czech Republic. Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Docekal, Vojtech $u Department of Organic Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Alblová, Miroslava $u Department of Structural Biology of Signaling Proteins, Institute of Physiology, Division BIOCEV, The Czech Academy of Sciences, Prague, Czech Republic. $7 xx0266819
- 700 1_
- $a Kohoutova, Klara $u Department of Structural Biology of Signaling Proteins, Institute of Physiology, Division BIOCEV, The Czech Academy of Sciences, Prague, Czech Republic. Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Schuster, Daniela $u Pharmaceutical Chemistry, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria. Department of Pharmaceutical and Medicinal Chemistry, Paracelsus Medical University Salzburg, Salzburg, Austria.
- 700 1_
- $a Aneichyk, Tatsiana $u Division of Molecular Pathophysiology, Biocenter, Medical University Innsbruck, Innsbruck, Austria. Independent Data Lab UG, Munich, Germany.
- 700 1_
- $a Vesely, Jan $u Department of Organic Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Obexer, Petra $u Department of Pediatrics II, Medical University Innsbruck, Innsbruck, Austria. Tyrolean Cancer Research Institute, Innsbruck, Austria.
- 700 1_
- $a Obsil, Tomas $u Department of Structural Biology of Signaling Proteins, Institute of Physiology, Division BIOCEV, The Czech Academy of Sciences, Prague, Czech Republic. Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic.
- 700 1_
- $a Ausserlechner, Michael J $u Department of Pediatrics I, Medical University Innsbruck, Innsbruck, Austria.
- 773 0_
- $w MED00188753 $t eLife $x 2050-084X $g Roč. 8, č. - (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31789593 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20211125091237 $b ABA008
- 999 __
- $a ok $b bmc $g 1595676 $s 1114033
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 8 $c - $e 20191204 $i 2050-084X $m eLife $n eLife $x MED00188753
- GRA __
- $a I3089-B28 $p Austrian Science Fund $2 International
- GRA __
- $a 17-33854L $p Grantová Agentura České Republiky $2 International
- LZP __
- $a Pubmed-20201125